Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Multi-site Trial of the Dietary Supplement Anatabine (RCP006) to Determine the Effects on Peripheral Markers of Inflammation in Patients With Elevated Levels of C-reactive Protein (CRP)

NCT01607619 is registered in ClinicalTrials.gov with Roskamp Institute Inc. as lead sponsor.

NCT NCT01607619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Multi-site Trial of the Dietary Supplement Anatabine (RCP006) to Determine the Effects on Peripheral Markers of Inflammation in Patients With Elevated Levels of C-reactive Protein (CRP)
Lead sponsor
Roskamp Institute Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2011
Completion date
January 31, 2013
Enrollment
117 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation